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Abstract: Exposure to elements in groundwater (toxic or beneficial) is commonplace yet, 
outside of lead and mercury, little research has examined the impact of many commonly 
occurring environmental exposures on mental abilities during the aging process. Inorganic 
arsenic  is  a  known  neurotoxin  that  has  both  neurodevelopmental  and  neurocognitive 
consequences. The aim of this study was to examine the potential association between 
current and long-term arsenic exposure and detailed neuropsychological functioning in a 
sample  of  rural-dwelling  adults  and  elders.  Data  were  analyzed  from  434  participants  
(133  men  and  301  women)  of  Project  FRONTIER,  a  community-based  participatory 
research study of the epidemiology of health issues of rural-dwelling adults and elders. The 
results  of the  study showed that GIS-based groundwater arsenic exposure (current and 
long-term) was significantly related to poorer scores in language, visuospatial skills, and 
executive  functioning.  Additionally,  long-term  low-level  exposure  to  arsenic  was 
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significantly  correlated  to  poorer  scores  in  global  cognition,  processing  speed  and 
immediate  memory.  The  finding  of  a  correlation  between  arsenic  and  the  domains  of 
executive functioning and memory is of critical importance as these are cognitive domains 
that  reflect  the  earliest  manifestations  of  Alzheimer’s  disease.  Additional  work  is 
warranted given the population health implications associated with long-term low-level 
arsenic exposure. 
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1. Introduction 
The  detrimental  impact  of  acute  high-level  exposure  to  arsenic  on  health  is  well  established; 
however,  prior  work  has  also  documented  adverse  consequences  of  prolonged  exposure  to 
groundwater  arsenic  at  levels  below  the  current  U.S.  standard  of  10  μg/L.  Chronic  exposure  to  
low-levels of arsenic through drinking water is common in the U.S. where 13.6% of sampled public 
water-supply systems exceeded 5 μg/L and 25% exceeded 2 μg/L [1]. Such exposure has been found to 
increase risk for a range of diseases including hypertension, diabetes, coronary artery disease, skin 
melanosis,  cancer,  and  poorer  cognition  [2-8].  Therefore,  over  40  million  Americans  are  at  an 
increased risk for negative health consequences resulting from being exposed to low-levels of arsenic 
over the course of their lifetime [1]. In fact, it has been proposed that exposure to environmental toxins, 
including arsenic, has caused a ―silent pandemic‖ in modern society that has gone undetected [9]. This 
circumstance  has  likely  remained  unnoticed  because  the  neurodevelopmental  and  neurotoxic 
consequences of in utero exposure (along with chronic lifetime exposure) may not become evident 
until neuronal attrition associated with aging occurs [9]. To date, however, no prior work has been 
published  looking  at  the  potential  impact  of  long-term  low-level  arsenic  exposure  on  cognitive 
functioning  among  adults  and  elders.  The  purpose  of  this  study  was  to  take  a  first-step  towards 
addressing this gap in the public health literature.  
There is ample reason to hypothesize an association between chronic arsenic exposure at low levels 
and  neuropsychological  dysfunction.  Inorganic  arsenic  at  high  doses  is  a  known  neurotoxin  with  
both  neurodevelopmental  and  neurocognitive  consequences.  From  a  neuropathological  standpoint,  
arsenic  exposure  has  been  associated  with  an  increase  in  the  production  of  β  amyloid  [10], 
hyperphosphorylation of tau protein [11], oxidative stress [12], inflammation [13,14], endothelial cell 
dysfunction [15] and angiogenesis [16], all of which have been linked to cognitive dysfunction and are 
proposed mechanisms underlying Alzheimer’s disease [3,17-19]. In animal models, arsenic exposure 
has been shown to cause morphologic and neurochemical alterations in the hippocampus and other 
memory-related  neuronal  structures  and  expected  learning  and  memory  deficits  have  been  
noted [15,20,21]. However, the direct link between chronic low-level arsenic exposure and detailed 
neuropsychological status remains untested.  
Despite the National Research Council’s call for epidemiological studies of the non-cancer health 
consequences of long-term low-level arsenic exposure [7,8], little research has been conducted to date. 
This is not for lack of interest; however, the methods for conducting such investigations have yet to be Int. J. Environ. Res. Public Health 2011, 8                 
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established. The ideal situation is one where a biomarker of chronic exposure is available, which is the 
case when considering lead. Bone lead level measurement via K-shell-x-ray fluorescence has been 
used  as  a  biomarker  of  long-term  exposure  [22]  and  the  correlation  between  such  exposure  and 
cognitive functioning has been studied  [23,24]. However, a valid biomarker for long-term arsenic 
exposure is lacking. One method that has been utilized is to reconstruct chronic exposures according to 
retrospective report of the level as well as the duration of exposure. In the PHYTHONER study, Baldi 
and  colleagues  [25]  have  documented  a  detrimental  impact  of  long-term  pesticide  exposures  on 
neurocognitive functioning among French vineyard workers using this approach. In countries where 
high levels of arsenic exposure have been documented for decades (e.g., areas of China, Bangladesh, 
and Mexico), researchers have historical data regarding exposure levels that can be utilized to create 
models of chronic exposure. In the U.S., the state of Texas offers a very unique situation given that the 
Texas Water Development Board (TWDB) has been monitoring well-water levels of a large number of 
chemicals including arsenic, for over 15 years across the state. Additionally, we have been conducting 
an epidemiological study of rural health, Project FRONTIER, for several years in two West Texas 
counties  with  mean  groundwater  arsenic  levels  that  are  below  the  U.S.  standard.  As  part  of  this 
protocol, we have collected subjects’ (1) exact residential location and (2) number of years living at 
that location. Therefore, combining data from the TWDB and Project FRONTIER can create estimates 
of current and long-term arsenic exposure. Groundwater arsenic concentration at each subject’s home 
can be estimated with Geographic Information System (GIS) approach (the ArcGIS program) based on 
the  residential  location’s  distances  to  surrounding  wells  with  known  groundwater  arsenic 
concentrations provided by TWDB. The purpose of the current study was to examine the potential 
association between current and long-term arsenic exposure estimated by the GIS methods and detailed 
neuropsychological functioning in a sample of rural-dwelling adults and elders. Based on our prior 
work, as well as work with children and adolescents, we hypothesized that increased low-level arsenic 
exposure would be significantly correlated with poorer scores in the domains of global cognition, 
executive functioning, memory, and language. 
2. Experimental Section 
2.1. Participants 
Data from 434 participants (133 men and 301 women) from Project FRONTIER were analyzed. 
Project FRONTIER is  an  ongoing epidemiological study of cognitive  aging among rural-dwelling 
individuals. Project FRONTIER utilizes a community-based participatory research (CBPR) approach, 
which  is  a  research  methodology  that  involves  partnering  communities  with  scientific  groups  to 
conduct  studies  of  human  disease  that  is  growing  rapidly  in  terms  of  use  and  acceptance  in  the 
scientific community. CBPR is particularly useful when working with underserved communities that 
may not respond to classic approaches (e.g., random digit dialing, mail surveys) and is very well suited 
to rural health research; CBPR is supported by and recommended for rural research by the National 
Institute of Environmental Health Sciences [26]. In Project FRONTIER, we have spent several years 
establishing and maintaining our community ties through local advisory boards, presentations, hiring 
of  local  workers  into  the  research  infrastructure,  and  partnering  with  community  entities  for Int. J. Environ. Res. Public Health 2011, 8                 
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completion of parts of the research protocol (i.e., blood work and medical examinations); our CBPR 
process for maintaining this translational research platform has been described in detail elsewhere [27]. 
Briefly, we partner with the local hospitals and clinics (who conduct the medical examinations and 
clinical  labs  as  well  as  provide  office  space)  as  well  as  the  senior  citizen’s  organizations.  Our 
community recruiters, community individuals, and research staff present information about the study at 
community  events  as  well  as  through  door-to-door  solicitation.  The  distribution  of  participants 
recruited into the study (Cochran Cohort & Parmer Cohort) as compared to all eligible individuals by 
county (Cochran County & Parmer County) by race/ethnicity, age, education, and gender are provided 
below in Figure 1. As can be seen from these figures, the demographic composition of our cohort 
closely resembles that of the eligible population from which they are drawn. 
Figure 1. Demographic comparison of enrolled participants (Cochran Cohort & Parmer 
Cohort) versus all eligible individuals in each county (Cochran County & Parmer County) 
for race/ethnicity, age, education, and gender. 
 
 
2.2. Procedures 
The protocol includes a standardized medical examination, clinical labs and neuropsychological 
testing, as well as an interview with the participant and a brief interview with an informant. Inclusion 
criteria  are  (1)  age  40  and  above  and  (2)  residing  in  one  of  the  counties  participating  in  Project 
FRONTIER. The two counties currently part of project FRONTIER are Cochran County and Parmer 
County, both located west of Lubbock, Texas, on the Texas—New Mexico border. The U.S. Census 
conducted in 2008 indicated that the Cochran County comprised 3,501 residents with 1,609 individuals 
age 40 and over (779 men and 830 women), compared to 9,639 residents for Parmer County including 
3,937 individuals age 40 and over (1,906 men and 2,031 women). Additionally, twenty-two percent of Int. J. Environ. Res. Public Health 2011, 8                 
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Cochran County inhabitants were reported to live below the poverty level, relative to 14% reported in 
Parmer  County.  The  principal  economic  land  use  in  Cochran  and  Parmer  County  is  large-scale 
irrigated  farming  (cotton  and  wheat),  ranching,  and  oil  and  natural  gas  production.  Participant 
recruitment is conducted by community recruiters through different means including brochures/flyers, 
presentations and events, as well as, in-person and/or door-to-door solicitation. All participants signed 
written informed consent and Project FRONTIER is conducted under an IRB approved protocol.  
The neuropsychological test battery was comprised of instruments covering a range of cognitive 
domains.  The  Mini-Mental  State  Examination  (MMSE)  [28]  is  the  most  commonly  administered 
psychometric screening assessment of global cognitive functioning. Since its development, there has 
been a wealth of literature published on the MMSE demonstrating it to be a relatively sensitive marker 
of dementia [29]. The Exit Interview (EXIT25) [30] is a well-validated global measure of executive 
control that covers a range of tasks including sequencing, fluency,  anomalous sentence repetition, 
thematic perception, automatic behaviors, go-no-go and automatic behavior, among others. EXIT25 
scores are significantly correlated with other validated measures of executive functioning [30]. Scores 
range from zero to 50 with higher scores suggestive of greater impairment; a score of 15 or greater best 
discriminates  non-demented  elderly  controls  from  those  with  dementing  illnesses.  The  Repeatable 
Battery for the Assessment of Neuropsychological Status (RBANS) [31] is a brief neuropsychological 
instrument that assesses multiple cognitive domains [32]. It contains 12 subtests that combine to create 
five  indices:  Attention,  Language,  Visuospatial/Constructional  abilities,  as  well  as  Immediate  and 
Delayed recall. The RBANS has accumulated a large amount of normative data [33] and has well 
established  psychometric  properties  [34].  The  Trails  Making  Test  (TMTA  and  TMTB),  is  a 
neuropsychological instrument that measures attention, processing speed and mental flexibility, and is 
considered to be a sensitive marker of cognitive dysfunction and decline [35]. The Controlled Oral 
Word  Association  Test  (COWAT)  [35]  assesses  both  phonemic  (FAS)  and  categorical  (Animal 
Naming) verbal fluency, both of which are standard neuropsychological assessment techniques with 
high sensitivity to cognitive dysfunction and dementia [35]. 
Determination of GIS-Arsenic. Geographic information system (GIS) is a way of displaying and 
analyzing geographically referenced information. GIS-based methods are commonly used to estimate 
environmental  exposures  [3,36-39].  We  used  the  Environmental  Systems  Research  Institute  [40] 
ArcGIS  (release  9.2)  program  to  plot  a  point  for  each  of  the  16,335  arsenic  ground  water 
measurements that are readily available from the Texas Water Development Board (TWDB) [41]. 
Through  inverse  distance  weighted  (IDW)  interpolation,  the  ArcGIS  software  builds  a  three 
dimensional surface map from a list of points. Each point’s influence is weighted based off its distance 
to that section of the map, which was generated using 12 well measurements from the TWDB within 
the immediate  geographic vicinity. Each  of the study participant’s  current residential address was 
geocoded  with  the  ArcGIS  StreetMap  data.  Finally,  GIS-arsenic  concentration  was  calculated  by 
extracting the estimated arsenic value from the IDW surface at each resident’s location. The maps of 
arsenic concentration in Texas  (left)  and  Texas  Panhandle  (right) are presented below (Figure 2). 
Arsenic groundwater levels are found to increase from Parmer County (15-year mean As level of  
3.0 μg/L) south to Cochran County (15-year mean As value of 7.4 μg/L with a maximum of 15.6 μg/L 
at the ―hot spot‖). Additionally, the length of residential history of residents from our pilot study 
suggests that large portions of the community are long-term residents averaging over 30 years living in Int. J. Environ. Res. Public Health 2011, 8                 
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their respective communities. Combined, these data demonstrate that the two counties selected for this 
study  provide  an  optimal  naturalistic  setting  to  investigate  long-term  low-level  arsenic  exposure  
from groundwater. 
Figure 2. Ground water arsenic measurements form the Texas Water Development Board (TWDB). 
 
Calculation  of  long-term  low-level  arsenic  exposure.  In  order  to  estimate  long-term  low-level 
arsenic exposure, we used readily available TWDB historical data and data from Project FRONTIER 
regarding current residential address as well as years living at that residence. We examined 15-years of 
TWDB water arsenic levels from wells within the communities of Project FRONTIER. We estimated 
long-term low-level exposure by multiplying current estimated arsenic levels by the number of years 
residing  in  current  home.  Similar  methods  for  estimating  long-term  exposure  have  been  utilized 
previously [42,43]. As part of a different research study, we pilot tested the comparability between 
observed and estimated (current) groundwater arsenic levels. We collected data from 7 rural wells and 
examined their actual values by an atomic fluorescence method [42,43] and compared these data with 
their respective GIS-estimated arsenic concentrations. GIS-estimated versus measured values are listed 
in Table 1. GIS-estimated arsenic concentrations were quite close to measured values except wells 
number 6 and 7, of which GIS-arsenic values are 4.6 and 4.2 μg/L higher than the measured values. 
However, the ranks of the two series of value are nearly identical (with the exception that rank 6 and 7 
based GIS approach for well #6 and #7 are a tie by measured values). 
Linear regression models were created with SPSS version 18 using raw neuropsychological test 
scores as outcome variables and either current or long-term arsenic exposure estimates as predictor 
variables. Covariates considered in the models included age, gender, education, ethnicity, language of 
administration, and APOE4 status (present/absent). Given that selenium is known to impact arsenic 
toxicity,  current  groundwater  selenium  estimates  were  also  calculated  via  GIS  methods  and  were 
entered into the models as a covariate. We utilized receiver operating characteristic (ROC) curves to 
estimate  the  accuracy  of  arsenic  levels  in  classifying  cognitive  status  (impairment  versus  no Int. J. Environ. Res. Public Health 2011, 8                 
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impairment) by reviewing the area under the ROC curve (AUC). Statistical significance was set at  
p < 0.05. 
Table 1. Comparison of GIS-estimated vs. measured arsenic concentration in seven wells (μg/L). 
Well #  GIS-Estimated  Measured 
1  12.9  14.2 
2  12.0  14.4 
3  11.6  13.3 
4  10.5  10.7 
5  7.0  5.8 
6  6.2  1.6 
7  5.8  1.6 
3. Results and Discussions 
The mean age and education of the 434 participants was 62.12 (sd = 12.81; range = 40–96) and  
10.84 (sd = 4.46; range = 0–20), respectively. Seventy-nine percent (n = 344) of the sample was tested in 
English, with the remainder completing the assessment in Spanish. Ninety-seven percent of the sample 
self-reported their racial status as White and 42% (n = 180) reported their ethnicity as Hispanic, with the 
majority (n  =  171) being of Mexican  American origin.  Of those  participants genotyped (n =  440),  
329 (75%) were APOE4 negative and 111 (25%) were APOE4 positive. Demographic characteristics of 
the sample are presented in Table 2. Estimated mean current arsenic level was 6.33 μg/L (sd = 3.03, 
range = 2.19–15.26). The 15-year mean arsenic concentrations in Parmer and Cochran County, TX were 
3.06 μg/L and 7.39 μg/L, respectively. In both counties, there was less than 2 μg/L variability over any 
given time period with results remaining very stable over this time period. There were 301 participants 
with all requisite data for calculation of long-term arsenic exposure at current household; mean long-term 
exposure was 240.15 μg/L-years (sd = 182.96; range = 2.87–972.83). On average, participants resided in 
their current residence for 34.12 years (sd = 20.01years, range = 1–80 years).  
Table 2. Demographic characteristics. 
  Mean (sd)  Range 
Age  62.12(12.8)  40–96 
Education  10.84 (4.46)  0–20 
MMSE  27.54 (2.80)  12–30 
Arsenic (μg/L)  6.33 (3.03)  2.19–15.26 
Long-Term Arsenic (μg/L-years)  240.15 (182.96)  2.87–972.83 
FAS Total  27.93 (12.62)  0–71 
Animal Naming  16.35 (5.01)  0–32 
TMTA (seconds)  56.73 (34.00)  18–420 
TMTB (seconds)  127.32 (77.67)  33–532 
RBANS Immediate Memory  41.11 (9.39)  5–61 
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Table 2. Cont. 
  Mean (sd)  Range 
RBANS Visuospatial  28.80 (6.26)  0–40 
RBANS Language  27.36 (5.46)  8–42 
RBANS Attention  45.51 (16.72)  9–100 
RBANS Delayed Memory  35.76 (9.25)  10–60 
EXIT-Total  7.31 (4.77)  0–23 
Note: RBANS scores are reflective of raw index scores. 
Current  estimated  groundwater  arsenic  exposure  level  was  significantly  associated  with  poorer 
scores in language (RBANS Language scores, B(SE) = −0.458 (0.171), p = 0.008), visuospatial skills 
(CLOX2, B(SE) = −0.118 (0.060), p = 0.048), and executive functioning (CLOX 1 B(SE) = −0.225 
(0.080),  p  =  0.005)  (see  Table  3).  Current  arsenic  exposure  significantly  classified  cognitive 
dysfunction (AUC = 0.58, 95% CI = 0.51–0.65, p = 0.03). 
Table 3. Arsenic levels impact on neuropsychological functioning. 
  Long-Term Arsenic  Current Arsenic 
  B (SE)  p-value  B (SE)  p-value 
MMSE  −0.003 (0.001)  0.004  −0.116 (0.088)  0.191 
CLOX 1  −0.001 (0.001)  0.290  −0.225 (0.080)  0.005 
CLOX 2  −0.001 (0.001)  0.038  −0.118 (0.060)  0.048 
FAS  −0.012 (0.004)  0.002  −0.724 (0.377)  0.056 
Animal Naming  −0.002 (0.002)  0.250  −0.138 (0.181)  0.446 
TMTA  0.034 (0.014)  0.016  0.986 (1.17)  0.400 
TMTB  0.037 (0.029)  0.209  4.23 (2.44)  0.084 
RBANS Immediate Memory  −0.010 (0.003)  0.003  0.187 (0.311)  0.547 
RBANS Visuospatial  −0.001 (0.002)  0.543  −0.342 (0.211)  0.106 
RBANS Language  −0.005 (0.002)  0.017  −0.458 (0.171)  0.008 
RBANS Attention  −0.007 (0.005)  0.118  −0.466 (0.423)  0.271 
RBANS Delayed Memory  0.001 (0.003)  0.651  0.537 (0.303)  0.077 
EXIT Total  0.006 (0.002)  0.000  0.475 (0.139)  0.077 
Note: Covariates included age, gender, education, language of administration (English or Spanish), 
selenium  level  and  APOE4  presence  (yes/no);  B  =  unstandardized  regression  coefficient;  
SE = standard error. 
Long-term low-level exposure to arsenic was significantly associated with poorer scores in global 
cognition (MMSE B(SE) = −0.003 (0.001), p = 0.004), visuospatial skills (CLOX 2 B(SE) = −0.001 
(0.001),  p  =  0.038),  language  (FAS  B(SE)  =  −0.012  (0.004),  p  =  0.002;  RBANS  Language  
B(SE) = −0.005 (0.002), p = 0.017), processing speed (TMTA B(SE) = 0.034 (0.014), p = 0.016), 
executive functioning (EXIT B(SE) = 0.006 (0.002), p < 0.001), and immediate memory (RBANS 
Immediate  Memory  B(SE)  =  −0.010  (0.003),  p  =  0.003).  Long-term  low-level  arsenic  exposure 
significantly classified cognitive impairment (AUC = 0 .62, 95% CI = 0.55–0.69, p = 0.001).  
With the rapidly growing number of elders world-wide, there is a great need for research examining 
factors that impact cognition among adults and elders. Prior work has consistently demonstrated the Int. J. Environ. Res. Public Health 2011, 8                 
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adverse  health  consequences  of  high  levels  of  arsenic  exposure.  As  a  result,  the  U.S.  acceptable 
standard of arsenic concentration was reduced in 2001 from 50 μg/L to 10 μg/L. However, as pointed 
out by the National Research Council, there remains a need for research examining the non-cancer 
health  effects  of  low-level  arsenic  exposure  [7,8]  using  longitudinal  methodologies.  Our  current 
findings suggest that long-term low-level arsenic exposure is detrimental for the cognitive status of 
adults  and  elders.  Our  findings  are  consistent  with  prior  work  linking  environmental  exposure  to 
arsenic  to  poorer  neuropsychological  functioning.  Bolla-Wilson  and  Bleeker  [44]  evaluated  the 
neurocognitive functioning of a 50-year-old adult following acute exposure to arsenic and documented 
deficits in learning and memory, which improved over time with no subsequent exposures. Similarly, 
Wright  and  colleagues  [45]  examined  the  neuropsychological  profile  of  31  school-aged  children 
residing in Ottawa County, Oklahoma, which contains the Tar Creek Superfund site, and found higher 
hair arsenic levels to be significantly associated with poorer scores on tests of intelligence and memory. 
Tsai  and  colleagues  [46]  evaluated  49  junior  school  students  and  found  that  higher  chronic 
groundwater arsenic exposure was significantly related to poorer memory and executive functioning 
(i.e., switching attention). In a sample of 602 school children age 6–8 years, Rosado and colleagues [47] 
found that higher urinary arsenic levels were significantly associated with poorer visuospatial skills, 
intelligence, attention and executive functioning. In our study, higher levels of current groundwater 
arsenic exposure (though still low-level exposure) was related to poorer visuospatial skills, language, 
and  executive  functioning.  Increased  levels  of  long-term  low-level  exposure  were  related  to 
significantly poorer performance in the domains of global cognition, language, executive functioning, 
as well as memory. The current study is, however, different from all of the previously conducted work 
in several ways. First, the mean and median values of groundwater exposures in the communities 
evaluated in this study are below the current U.S. acceptable standard and are therefore reflective of 
low-level exposure. Second, we examined the impact of exposure on neuropsychological functioning 
in a community-based sample of rural-dwelling adults and elders rather than school children. Lastly, 
ours is the first to study the impact of estimated long-term low-level arsenic exposure on detailed 
neuropsychological functioning. Our results are consistent with and extend prior work to adults and 
elders exposed at lower levels of groundwater arsenic [3].  
The consistent finding of arsenic being related to the domains of executive functioning and memory 
is of critical importance as these are cognitive domains that may change as part of the normal aging 
process and may even be the earliest manifestations of Alzheimer’s disease [48,49]. This is particularly 
important for the long-term estimates, which as can be seen from Table 3, are more strongly related 
with  cognitive  status.  Therefore,  it  is  possible  that  the  impact  of  low-level  arsenic  exposure  on 
neuropsychological  functioning  happens  over  time,  which  fits  with  the  developmental  course  of 
Alzheimer’s disease. Alzheimer’s disease is a disease of insidious onset with slow progression that 
begins decades before clinical manifestation. While it has been suggested that research should focus on 
preventative strategies for Alzheimer’s disease [50], the recent NIH consensus panel suggested that 
there are no preventative strategies currently available for Alzheimer’s disease, albeit dietary factors 
were suggested as having promise. The notion of groundwater exposure to arsenic as a risk factor for 
late-life  Alzheimer’s  disease  offers  potential  for  the  first  ever  population-wide  preventative  effort 
aimed at preventing and/or delaying onset of this disease, which could be accomplished by revision of 
the Safe Drinking Water Act (SDWA).  Int. J. Environ. Res. Public Health 2011, 8                 
 
 
870 
There are limitations to the current study. One limitation is the cross-sectional nature of the data, 
which  does  not  allow  for  inference  of  causality.  Longitudinal  assessment  of  this  topic  will  be 
conducted through Project FRONTIER as follow-up waves are completed. The key limitation to the 
current study is the lack of either a biomarker of arsenic exposure (i.e., blood, hair, or nail levels) or 
direct measurement of the actual water arsenic levels at participant homes. However, the existence of 
the TWDB data provides an exceptional opportunity to model chronic arsenic exposure and the state 
can serve as a naturalistic setting for future studies. This is due to the fact that there are several ―hot 
beds‖ of high arsenic levels across the state, even though the majority of the state is well below the 
current EPA standard. It is shown that GIS-estimated arsenic concentrations are very close to the 
measured values, particularly in terms of rank. Future Project FRONTIER studies will examine serum 
arsenic levels along with current household water levels. We cannot at this point conclude that long-
term low-level arsenic consumption through water is causally related to poorer cognition from the 
current data. However, we can assert that those individuals who have resided for long periods of time 
in regions that have historically low levels of arsenic in groundwater supplies are at increased risk for 
cognitive dysfunction. This finding is certainly novel and warrants further investigation. 
4. Conclusions 
Our findings suggest an association between low-level arsenic exposure and neuropsychological 
functioning, as originally hypothesized. Of particular interest is the association between long-term 
low-level arsenic exposure and neuropsychological functioning across a broader range of domains than 
current  exposure.  Our  findings  offer  the  first  direct  evidence  that  low  level  arsenic  exposure, 
extrapolated from current arsenic levels and self report of duration in residence is associated with 
poorer  neuropsychological  functioning  among  community-dwelling  adults  and  elders  in  the  U.S. 
Further research is needed to investigate this topic and, if cross-validated, this research will provide 
ample  justification  for  a  re-evaluation  of  current  policy  related  to  acceptable  groundwater  
arsenic levels.  
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